A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical trial NCT05431179 · WITHDRAWN

Trial details

NCT number: NCT05431179
Sponsor: Oncternal Therapeutics, Inc
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Mantle-Cell Lymphoma Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases Lymphoma, Non-Hodgkin Lymphoma, B-Cell

Start date: 2023-03-01
Primary completion: 2026-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.